Cargando…
Mitochondria-targeting theranostics
BACKGROUND: Interest in subcellular organelle-targeting theranostics is substantially increasing due to the significance of subcellular organelle-targeting drug delivery for maximizing therapeutic effects and minimizing side effects, as well as the significance of theranostics for delivering therape...
Autor principal: | Kang, Han Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225566/ https://www.ncbi.nlm.nih.gov/pubmed/30455977 http://dx.doi.org/10.1186/s40824-018-0145-7 |
Ejemplares similares
-
Mitochondria-targeted aggregation induced emission theranostics: crucial importance of in situ activation
por: Shin, Weon Sup, et al.
Publicado: (2016) -
Towards Water Soluble Mitochondria-Targeting Theranostic Osmium(II) Triazole-Based Complexes
por: Omar, Salem A. E., et al.
Publicado: (2016) -
Hyaluronic Acid-Based Theranostic Nanomedicines for Targeted Cancer Therapy
por: Lee, So Yun, et al.
Publicado: (2020) -
Targeted theranostic photoactivation on atherosclerosis
por: Song, Joon Woo, et al.
Publicado: (2021) -
CXCR4-targeted theranostics in oncology
por: Buck, Andreas K., et al.
Publicado: (2022)